Intraoperative radiotherapy: health professional and patient preferences, quality of life and cosmesis - secondary endpoints of the TARGIT-A Trial

  • Tammy Corica

Research output: ThesisDoctoral Thesis

400 Downloads (Pure)

Abstract

Early breast cancer is usually treated with a combination of surgery and radiotherapy. Standard external beam radiotherapy takes 2-6 weeks to complete. In the International randomised controlled TARGIT-A Trial, a single dose of intra-operative radiotherapy was compared to standard radiotherapy. Tammy Corica investgated cosmetic and quality of life outcomes and health professional and patient preferences as secondary endpoints of TARGIT-A. The single dose was found to be acceptable by patients and health professionals, improved treatment-related quality of life and did not adversely affect cosmetic outcome; all are important points for patients and their doctors to consider when making treatment-related decisions.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • The University of Western Australia
Supervisors/Advisors
  • Nowak, Anna, Supervisor
  • Joseph, David, Supervisor
  • Saunders, Christobel, Supervisor
  • Bulsara, Mahesh, Supervisor
Award date23 May 2018
DOIs
Publication statusUnpublished - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Intraoperative radiotherapy: health professional and patient preferences, quality of life and cosmesis - secondary endpoints of the TARGIT-A Trial'. Together they form a unique fingerprint.

Cite this